Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-12

FDA Approved: IRBESARTAN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for IRBESARTAN (irbesartan) from Aurobindo Pharma Limited. This action approves changes under the ANDA for the generic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)